\-\ Texto\\:\\ \ \(0\)\
\-\ hemoccult\\ stool\\ testing\\ was\\ positive\\ for\\ blood\ \(0\)\
\-\ due\\ to\\ the\\ metastatic\\ disease\\,\\ chemotherapy\\ is\\ ongoing\\.\\ \\ diverting\\ colostomy\\ was\\ performed\\ as\\ well\\.\ \(0\)\
\-\ axial\\ ct\\ images\\ demonstrate\\ abnormal\\ pericolonic\\ soft\\-tissue\\ stranding\\ and\\ nodularity\\.\\ \\ abnormal\\ lymph\\ nodes\\ are\\ seen\\ in\\ the\\ colonic\\ mesentery\\.\\ \\ hypoattenuating\\ enhancing\\ liver\\ lesions\\ are\\ noted\\.\\ \\ gi\\ fluoroscopy\\ \\(single\\ contrast\\ enema\\)\\ reveals\\ a\\ constricting\\ submucosal\\ lesion\\ near\\ the\\ hepatic\\ flexure\\.\ \(0\)\
\-\ colon\\ cancer\ \(55\)\
\-\ colon\\ cancer\ \(55\)\
\-\ focal\\ colonic\\ infection\ \(0\)\
\-\ ischemia\ \(171\)\
\-\ 61\\ y\\.o\\.\\ man\\ with\\ intermittent\\ lower\\ abdominal\\ pain\\ and\\ constipation\\;\\ the\\ patient\\ has\\ never\\ had\\ an\\ optical\\ colonoscopy\\ screenng\\ exam\\ \\(he\\ refused\\ further\\ testing\\ after\\ a\\ bad\\ experience\\ with\\ a\\ flexible\\ sigmoidoscopy\\)\\.\ \(1\)\
\-\ colon\\ cancer\\ screening\\ with\\ optical\\ colonoscopy\\ is\\ underutilized\\ \\(many\\ patients\\ do\\ not\\ get\\ this\\ test\\ due\\ to\\ fear\\ of\\ the\\ exam\\,\\ financial\\ contraints\\,\\ access\\ problems\\,\\ etc\\)\\.\\ \\ as\\ ct\\ colonography\\ \\(ctc\\)\\ continues\\ to\\ gain\\ favor\\,\\ finding\\ pre\\-malignant\\ adenomatous\\ polyps\\ before\\ they\\ become\\ malignant\\ colon\\ cancers\\ is\\ important\\ if\\ we\\ are\\ to\\ decrease\\ mortality\\ from\\ colon\\ cancer\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ colon\\:\\ 0\\.09374114273246757\ \(0\)\
\-\ optical\\:\\ 0\\.0830080900876716\ \(0\)\
\-\ cancer\\:\\ 0\\.0627746427791009\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.05571929639639557\ \(0\)\
\-\ colonic\\:\\ 0\\.05202944514644498\ \(0\)\
\-\ screenng\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ underutilized\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ contraints\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ pre\\-malignant\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ testing\\:\\ 0\\.046183097171422105\ \(0\)\
\-\ financial\\:\\ 0\\.045376375661489124\ \(0\)\
\-\ ctc\\:\\ 0\\.045376375661489124\ \(0\)\
\-\ sigmoidoscopy\\:\\ 0\\.043111207459767535\ \(0\)\
\-\ hemoccult\\:\\ 0\\.0415040450438358\ \(0\)\
\-\ fear\\:\\ 0\\.04025743302532066\ \(0\)\
\-\ colonography\\:\\ 0\\.03923887684211421\ \(0\)\
\-\ diverting\\:\\ 0\\.03837769985983902\ \(0\)\
\-\ constricting\\:\\ 0\\.03837769985983902\ \(0\)\
\-\ flexible\\:\\ 0\\.03837769985983902\ \(0\)\
\-\ refused\\:\\ 0\\.036973708640392615\ \(0\)\
\-\ bad\\:\\ 0\\.036973708640392615\ \(0\)\
\-\ colostomy\\:\\ 0\\.03536654622446088\ \(0\)\
\-\ pericolonic\\:\\ 0\\.034919380259804254\ \(0\)\
\-\ favor\\:\\ 0\\.032799326507262895\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.03224020104046411\ \(0\)\
\-\ gain\\:\\ 0\\.03224020104046411\ \(0\)\
\-\ adenomatous\\:\\ 0\\.03198031268496191\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.030436997731731977\ \(0\)\
\-\ submucosal\\:\\ 0\\.030247603588292416\ \(0\)\
\-\ access\\:\\ 0\\.030247603588292416\ \(0\)\
\-\ ongoing\\:\\ 0\\.030064420220566213\ \(0\)\
\-\ nodularity\\:\\ 0\\.030064420220566213\ \(0\)\
\-\ flexure\\:\\ 0\\.029386426606017233\ \(0\)\
\-\ constipation\\:\\ 0\\.029386426606017233\ \(0\)\
\-\ mesentery\\:\\ 0\\.02922904740508597\ \(0\)\
\-\ get\\:\\ 0\\.02922904740508597\ \(0\)\
\-\ polyps\\:\\ 0\\.02892699588960957\ \(0\)\
\-\ soft\\-tissue\\:\\ 0\\.02878188144042934\ \(0\)\
\-\ cancers\\:\\ 0\\.02878188144042934\ \(0\)\
\-\ 61\\:\\ 0\\.028107982067308586\ \(0\)\
\-\ never\\:\\ 0\\.028107982067308586\ \(0\)\
\-\ abnormal\\:\\ 0\\.02723008089737331\ \(0\)\
\-\ enema\\:\\ 0\\.02666182768788798\ \(0\)\
\-\ stool\\:\\ 0\\.026282930501637918\ \(0\)\
\-\ experience\\:\\ 0\\.026192089602912888\ \(0\)\
\-\ mortality\\:\\ 0\\.02601472257322249\ \(0\)\
\-\ etc\\:\\ 0\\.025842813865586997\ \(0\)\
\-\ due\\:\\ 0\\.025477957016232847\ \(0\)\
\-\ we\\:\\ 0\\.025128660952123957\ \(0\)\
\-\ continues\\:\\ 0\\.024909550822776017\ \(0\)\
\-\ stranding\\:\\ 0\\.023091548585711053\ \(0\)\
\-\ become\\:\\ 0\\.02274070556202932\ \(0\)\
\-\ ischemia\\:\\ 0\\.02218620858942965\ \(0\)\
\-\ problems\\:\\ 0\\.022098916310641488\ \(0\)\
\-\ decrease\\:\\ 0\\.021844936567195914\ \(0\)\
\-\ nodes\\:\\ 0\\.021562521599805796\ \(0\)\
\-\ gi\\:\\ 0\\.02144572447791019\ \(0\)\
\-\ important\\:\\ 0\\.02144572447791019\ \(0\)\
\-\ exam\\:\\ 0\\.02097468089329093\ \(0\)\
\-\ do\\:\\ 0\\.020723871229418534\ \(0\)\
\-\ near\\:\\ 0\\.02065656207569689\ \(0\)\
\-\ intermittent\\:\\ 0\\.02049175389470975\ \(0\)\
\-\ test\\:\\ 0\\.020395153352195442\ \(0\)\
\-\ screening\\:\\ 0\\.020363320832001937\ \(0\)\
\-\ before\\:\\ 0\\.020206823422908787\ \(0\)\
\-\ hepatic\\:\\ 0\\.01993572263578778\ \(0\)\
\-\ many\\:\\ 0\\.019621304558142025\ \(0\)\
\-\ are\\:\\ 0\\.019523025796585502\ \(0\)\
\-\ single\\:\\ 0\\.019350057488773362\ \(0\)\
\-\ lymph\\:\\ 0\\.019271186642148865\ \(0\)\
\-\ reveals\\:\\ 0\\.01867736173349175\ \(0\)\
\-\ malignant\\:\\ 0\\.017255143443459783\ \(0\)\
\-\ they\\:\\ 0\\.017200816349091097\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.017111428967267403\ \(0\)\
\-\ liver\\:\\ 0\\.016459338049344824\ \(0\)\
\-\ \\(\\:\\ 0\\.01614216148030973\ \(0\)\
\-\ \\)\\:\\ 0\\.015944976360073856\ \(0\)\
\-\ positive\\:\\ 0\\.015490980951307916\ \(0\)\
\-\ finding\\:\\ 0\\.015385818463902131\ \(0\)\
\-\ further\\:\\ 0\\.015181252188828258\ \(0\)\
\-\ enhancing\\:\\ 0\\.014971807446283571\ \(0\)\
\-\ as\\:\\ 0\\.014442206769766791\ \(0\)\
\-\ infection\\:\\ 0\\.013877187564652555\ \(0\)\
\-\ y\\.o\\:\\ 0\\.013778656047970392\ \(0\)\
\-\ focal\\:\\ 0\\.013634042481220124\ \(0\)\
\-\ axial\\:\\ 0\\.01362453338585403\ \(0\)\
\-\ ct\\:\\ 0\\.013355348082592658\ \(0\)\
\-\ he\\:\\ 0\\.013319482357726366\ \(0\)\
\-\ performed\\:\\ 0\\.013310493470543682\ \(0\)\
\-\ blood\\:\\ 0\\.013030229455359215\ \(0\)\
\-\ if\\:\\ 0\\.012953873931735393\ \(0\)\
\-\ lesions\\:\\ 0\\.012779667633206412\ \(0\)\
\-\ patients\\:\\ 0\\.012355165359586737\ \(0\)\
\-\ metastatic\\:\\ 0\\.012017370969922293\ \(0\)\
\-\ abdominal\\:\\ 0\\.011932509710179414\ \(0\)\
\-\ noted\\:\\ 0\\.011315202170126222\ \(0\)\
\-\ \\;\\:\\ 0\\.011315202170126222\ \(0\)\
\-\ man\\:\\ 0\\.01129012202843575\ \(0\)\
\-\ was\\:\\ 0\\.011042206952108233\ \(0\)\
\-\ demonstrate\\:\\ 0\\.010985766152698551\ \(0\)\
\-\ well\\:\\ 0\\.01079933493278576\ \(0\)\
\-\ lower\\:\\ 0\\.010736659605384708\ \(0\)\
\-\ contrast\\:\\ 0\\.010685897691664276\ \(0\)\
\-\ had\\:\\ 0\\.010300836978998371\ \(0\)\
\-\ after\\:\\ 0\\.009877101690554203\ \(0\)\
\-\ lesion\\:\\ 0\\.009723772212293043\ \(0\)\
\-\ to\\:\\ 0\\.009543421417720363\ \(0\)\
\-\ seen\\:\\ 0\\.0094336738271938\ \(0\)\
\-\ is\\:\\ 0\\.009423867794157412\ \(0\)\
\-\ images\\:\\ 0\\.009157898837705888\ \(0\)\
\-\ has\\:\\ 0\\.008964804304437307\ \(0\)\
\-\ disease\\:\\ 0\\.00780300302355142\ \(0\)\
\-\ \\,\\:\\ 0\\.0075617336736672446\ \(0\)\
\-\ from\\:\\ 0\\.007075059850023533\ \(0\)\
\-\ not\\:\\ 0\\.006898428333753829\ \(0\)\
\-\ a\\:\\ 0\\.00664692405282572\ \(0\)\
\-\ an\\:\\ 0\\.006601479688741508\ \(0\)\
\-\ pain\\:\\ 0\\.005830213226428686\ \(0\)\
\-\ this\\:\\ 0\\.005369481638626441\ \(0\)\
\-\ patient\\:\\ 0\\.004785429781655799\ \(0\)\
\-\ for\\:\\ 0\\.0040732298806855595\ \(0\)\
\-\ the\\:\\ 0\\.0038617118632297705\ \(0\)\
\-\ in\\:\\ 0\\.00235417447005729\ \(0\)\
\-\ and\\:\\ 0\\.002011273807063893\ \(0\)\
\-\ \\.\\:\\ 0\\.001983214307114317\ \(0\)\
\-\ with\\:\\ 0\\.0019609638450819506\ \(0\)\
\-\ of\\:\\ 0\\.0006508592223351309\ \(0\)\
